Cargando…

Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study

BACKGROUND: Diabetes mellitus is a recognized risk factor for esophageal squamous cell carcinomas (ESCC), and metformin is a recognized protective factor for some gastrointestinal tumors. But knowledge is limited regarding the effect of metformin on survival outcome of ESCC patients with type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Huang-He, Fu, Jun-Hui, Hao, Zhe-Xue, Wu, He-Fang, Zhong, Qiang, Wang, Fan, Liu, Hang-Hui, Gu, Xiang-Sen, Wang, Bin, Huang, Hao-Da, Li, Zhuo-Yi, He, Jian-Xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138989/ https://www.ncbi.nlm.nih.gov/pubmed/32274150 http://dx.doi.org/10.21037/jtd.2019.12.98

Ejemplares similares

Clinical Significance of Preoperative Thrombin Time in Patients with Esophageal Squamous Cell Carcinoma following Surgical Resection
por: Li, Xiao-Hui, et al.
Publicado: (2015)

Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma
por: Chen, You-Fang, et al.
Publicado: (2013)

The role of endoscopic tumor length in resected esophageal squamous cell carcinoma: a retrospective study
por: Chen, Peng, et al.
Publicado: (2021)

Cancer stem cells in esophageal squamous cell cancer
por: Wu, Qian, et al.
Publicado: (2019)

Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions
por: Yu, Hongliang, et al.
Publicado: (2016)

Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway
por: He, Yindi, et al.
Publicado: (2018)

Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2015)

Effects of EHD2 interference on migration of esophageal squamous cell carcinoma
por: Li, Mei, et al.
Publicado: (2013)

Artificial intelligence for diagnosing microvessels of precancerous lesions and superficial esophageal squamous cell carcinomas: a multicenter study
por: Yuan, Xiang-Lei, et al.
Publicado: (2022)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma
por: Liang, Yi, et al.
Publicado: (2012)

Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022)

Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs
por: Zhang, Zhihui, et al.
Publicado: (2021)

Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma
por: He, Xiao, et al.
Publicado: (2019)

Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study
por: Li, Kexun, et al.
Publicado: (2023)

Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma
por: Li, Zhengqi, et al.
Publicado: (2021)

The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection
por: Song, Qian, et al.
Publicado: (2020)

Prognostic Significance of Baseline Neutrophil Count and Lactate Dehydrogenase Level in Patients With Esophageal Squamous Cell Cancer Treated With Radiotherapy
por: Luo, He-San, et al.
Publicado: (2020)

Importance of colonoscopy in patients undergoing endoscopic resection for superficial esophageal squamous cell carcinoma
por: Tominaga, Kei, et al.
Publicado: (2016)

Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma
por: Chen, Jie, et al.
Publicado: (2019)

Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis
por: Luo, He-San, et al.
Publicado: (2019)

Combination of Endoscopic Resection and Radiofrequency Ablation for the Treatment of Esophageal Squamous Cell Neoplasia With Multiple Lugol-Voiding Lesions
por: Chen, Zhihao, et al.
Publicado: (2021)

Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma
por: Li, Rutao, et al.
Publicado: (2022)

Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma
por: Hou, Xue, et al.
Publicado: (2016)

Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer
por: Wu, Sheng-Xi, et al.
Publicado: (2017)

High-dose chemotherapy sensitizes locally advanced esophageal squamous cell carcinoma to PD-1 blockade for a higher pathological complete response rate and survival
por: Wang, Peiyuan, et al.
Publicado: (2023)

Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
por: Luo, He-San, et al.
Publicado: (2019)

Endoscopic resections for superficial esophageal squamous cell epithelial neoplasia: focus on histological discrepancies between biopsy and resected specimens
por: Yang, Lang, et al.
Publicado: (2021)

Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma
por: Yang, Weixiong, et al.
Publicado: (2022)

Risk prediction nomogram for major morbidity related to primary resection for esophageal squamous cancer
por: Liu, Xiao-long, et al.
Publicado: (2021)

Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma
por: Chen, Linyan, et al.
Publicado: (2018)

Prognostic and predictive significance of tumor length in patients with esophageal squamous cell carcinoma undergoing radical resection
por: Wu, Jie, et al.
Publicado: (2016)

Adjuvant Therapy for a Microscopically Incomplete Resection Margin after an Esophagectomy for Esophageal Squamous Cell Carcinoma
por: Qiu, Bo, et al.
Publicado: (2017)

Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma
por: Gao, Yibo, et al.
Publicado: (2019)

Precision screening for esophageal squamous cell carcinoma in China
por: He, Zhonghu, et al.
Publicado: (2020)

Development and validation of a novel prognostic model for patients with surgically resected esophageal squamous cell carcinoma
por: Hu, Haiyang, et al.
Publicado: (2022)

Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma
por: Huang, Yi, et al.
Publicado: (2023)

Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
por: Feng, Y, et al.
Publicado: (2014)

Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma
por: Qin, Hui, et al.
Publicado: (2019)

Economic evaluation of tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
por: Shi, Fenghao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4o35q6ipjao0j55q7mi07sqpm5